Health-care companies ticked down as traders rotated back into cyclical sectors after relatively benign inflation data.
Roche Holdings is pushing forward with a longstanding plan to enter the gene-sequencing business, 10 years after a failed takeover bid for Illumina.
The Food and Drug Administration granted emergency-use authorization to Zoetis for a drug that treats New World screwworm infestations in dogs and puppies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.